Community pharmacy COPD services: what do researchers and policy makers need to know?

Twigg, Michael and Wright, David (2017) Community pharmacy COPD services: what do researchers and policy makers need to know? Integrated Pharmacy Research and Practice, 2017 (6). pp. 53-59. ISSN 2230-5254

[img] PDF (Accepted manuscript) - Submitted Version
Restricted to Repository staff only until 31 December 2099.

Download (451kB) | Request a copy

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality across the world and is responsible for a disproportionate use of healthcare resources. It is a progressive condition which is largely caused by smoking. Identification of early stage COPD provides an opportunity for interventions, such as smoking cessation, which prevent its progression. Once diagnosed, ongoing support services potentially provide an opportunity to assist the patient in managing their condition and working more closely with the rest of the primary care team. Whilst there are a number of robust studies which have demonstrated the role which pharmacists could undertake to identify and prevent disease progression adoption of such services is currently limited. As a service which would seem to be appropriate for adoption in all societies where smoking is prevalent we have performed a review of reported approaches that have been used when setting up and evaluating such services and therefore aim to inform researchers and policy makers in other countries on how best to proceed. Implementation science has been used to further contextualise the findings of the review in terms of components that are likely to enhance the likelihood of implementation. With reference to screening services we have made clear recommendations as to the identification of patients, structure and smoking cessation elements of the programme. Further work needs to be undertaken by policy makers to determine the approaches that can be used to motivate pharmacists to provide this service. In terms of ongoing support services, there is some evidence to suggest that these would be effective and cost-effective to the health service in which is implemented. However, the capability, opportunity and motivation of pharmacists to provide these, more complex, services needs to be the focus for researchers prior to implementation by policy makers.

Item Type: Article
Uncontrolled Keywords: chronic obstructive pulmonary disease,community pharmacy,screening,spirometry,smoking cessation
Faculty \ School: Faculty of Science > School of Pharmacy
Depositing User: Pure Connector
Date Deposited: 09 Dec 2016 00:06
Last Modified: 17 Mar 2020 22:43
URI: https://ueaeprints.uea.ac.uk/id/eprint/61668
DOI: 10.2147/IPRP.S105279

Actions (login required)

View Item View Item